TickerSpark Feed

LEGN coverage

Every article, report, and earnings note where LEGN appears.

Inside the Obsidian Therapeutics IPO: Reverse-Merger Setup, Risks, and Watchpoints

Obsidian Therapeutics, Inc. Common Stock (NASDAQ: OBX) is expected to list on 2026-08-04, but the price range has not been disclosed. The company is coming to market through an all-stock reverse merger with Galera Therapeutics rather than a traditional IPO. Bull case: a differentiated cell-therapy platform with strong strategic backing; bear case: no disclosed pricing, no commercial revenue, and heavy clinical risk.

Aug 4, 2026·5 MIN

IPO NASDAQ

IPOSLBT

What to Watch as SL Science Holding Limited Prices on Nasdaq

SL Science Holding Limited Ordinary Shares (SLBT) is expected to list on Nasdaq on 2026-06-15, but the price range has not been disclosed. This is a de-SPAC listing rather than a traditional IPO, so the key question is whether the market gives credit to a small-revenue biotech platform with a very large headline valuation.

Jun 13, 2026·6 MIN

IPO NASDAQ

On-Demand Research

Want a deeper dive on LEGN?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate LEGN Report

For Active Investors

Stock research for every investor

Reports on any stock
Daily market intelligence
AI analyst in your pocket
Portfolio analysis tools

Get Full Access →

Cancel anytime

Today's Top MoverPSTG

▲9.14%

Everpure, Inc · $86.22

Inside the Obsidian Therapeutics IPO: Reverse-Merger Setup, Risks, and Watchpoints

What to Watch as SL Science Holding Limited Prices on Nasdaq

Want a deeper dive on LEGN?

A new stock idea, every evening.

Stock research for every investor